MTMT-ben szereplő publikációk tallózása szerző szerint "Schirmacher P"

1-3 / 3

Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions

Tátrai, Péter; Somorácz, Áron; Batmunkh E; Schirmacher P; Kiss, András; Schaff, Zsuzsa; Nagy, Péter; Kovalszky, Ilona (2009)
Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types

Budczies J; Denkert C; Győrffy, Balázs; Schirmacher P; Stenzinger A (2017)

BACKGROUND: Inhibition of the PD-L1/PD-1 immune checkpoint axis represents one of the most promising approaches of immunotherapy for various cancer types. However, immune checkpoint inhibition is successful only in ...
Claudins and tricellulin in fibrolamellar hepatocellular carcinoma

Patonai, Attila; Erdélyi-Belle, Boglárka; Korompay, Anna; Somorácz, Áron; Straub BK; Schirmacher P; Kovalszky, Ilona; Lotz, Gábor; Kiss, András; Schaff, Zsuzsa (2011)

1-3 / 3

Keresés